20 Nov 2026, 09:32
Company Administration—
Announcement history available from 1 August 2025
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 20 Nov 2026, 09:32 | Board Changes and Final Director's Interest Notice | Company Administration | — | 02010, 12001 | |
| 19 Nov 2026, 14:39 | BDX: BCAL Position on GSS-MAP Merger | Other | — | — | |
| 18 Nov 2026, 14:03 | Withdrawal of Resolution 4 - Addendum to Notice of AGM | Meetings & Governance | — | 08005 | |
| 18 Nov 2026, 13:12 | MAP: Proposed Merger with GSS not proceeding | Other | — | — | |
| 18 Nov 2026, 09:57 | End of Proposed Merger with Microba Life Sciences | Mergers & Acquisitions | MS | 01012, 01014, 01015, 09014 | |
| 16 Nov 2026, 09:21 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 13 Nov 2026, 17:29 | TOV: GSS - Panel Receives Application | Mergers & Acquisitions | MS | 01009, 01012 | |
| 12 Nov 2026, 19:26 | Postponement of AGM & Further Addendum to the Notice of AGM | Meetings & Governance | — | 08005 | |
| 2 Nov 2026, 14:39 | Notification regarding unquoted securities - GSS | Securities Administration | — | 06021 | |
| 2 Nov 2026, 08:56 | 3X Initial Directors Interest Notice | Director Interests | — | 02008 | |
| 28 Oct 2026, 16:07 | BDX: BCAL Welcomes Dr John Melki's Appointment to GSS Board | Other | — | — | |
| 28 Oct 2026, 10:58 | Results of 2026 EGM and Appointment of Director | Meetings & Governance | — | 08003, 12001 | |
| 23 Oct 2026, 19:52 | Addendum to Notice of Annual General Meeting | Mergers & Acquisitions | MS | 01012, 08001, 08004, 16002 | |
| 21 Oct 2026, 09:18 | Update on Commercial Terms for the Proposed Merger with MAP | Mergers & Acquisitions | MS | 01012 | |
| 16 Oct 2026, 20:25 | Response to Media Speculation & BCAL letter to GSS | Meetings & Governance | MS | 02006, 08006, 11004 | |
| 16 Oct 2026, 09:09 | 2026 Notice of Annual General Meeting | Meetings & Governance | — | 08001, 08004 | |
| 8 Oct 2026, 12:36 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19001, 19006 | |
| 28 Sept 2026, 14:55 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 23 Sept 2026, 14:03 | Notice of Extraordinary General Meeting | Meetings & Governance | — | 08002, 08004 | |
| 22 Sept 2026, 09:46 | GSS Investor Presentation - Proposed Merger with MAP | Presentations | MS | 03026 | |
| 22 Sept 2026, 09:25 | GSS and MAP agree to Commercial Terms for Merger | Mergers & Acquisitions | MS | 01012, 01015 | |
| 17 Sept 2026, 09:49 | Receipt of Section 249D Notice from BCAL Diagnostics | Meetings & Governance | MS | 08006 | |
| 14 Sept 2026, 09:49 | Date of AGM and Closing Date for Director Nominations | Meetings & Governance | — | 08006 | |
| 3 Sept 2026, 09:37 | BDX Holdings of GSS Shares and receipt of Section 249D | Meetings & Governance | MS | 02006, 08006 | |
| 1 Sept 2026, 12:12 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 31 Aug 2026, 08:39 | Board Changes | Company Administration | — | 12001, 12017 | |
| 27 Aug 2026, 16:24 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 26 Aug 2026, 09:30 | Genetic Signatures and Microba in Merger Discussions | Company Update | MS | 11001 | |
| 26 Aug 2026, 08:35 | Change in Substantial Shareholder Notice from BDX | Substantial Holders | — | 02002 | |
| 25 Aug 2026, 14:12 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 25 Aug 2026, 09:29 | FY26 Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 25 Aug 2026, 09:25 | FY26 Market Update | Financial Results | MS | 03003, 03026 | |
| 25 Aug 2026, 09:15 | FY26 Results Release | Financial Results | MS | 03003 | |
| 25 Aug 2026, 09:09 | FY26 Appendix 4E and Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 24 Aug 2026, 10:16 | FY 26 Annual Results and Investor Webinar Notification | Presentations | — | 03027, 14014 | |
| 21 Aug 2026, 09:26 | Commercial Testing Commences at Hvidovre Hospital in Denmark | Company Update | — | 11001 | |
| 23 July 2026, 14:11 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 2 July 2026, 17:13 | Becoming a substantial holder from BDX | Substantial Holders | — | 02001 | |
| 2 July 2026, 14:41 | GSS responds to the BCAL Diagnostics Announcement | Company Administration | MS | 12008 | |
| 2 July 2026, 10:04 | BDX: BCAL to Acquire Shares in Genetic Signatures | Other | MS | — | |
| 1 July 2026, 12:20 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 19 June 2026, 08:58 | Change of Company Secretary | Company Administration | — | 12007 | |
| 18 June 2026, 16:55 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 16 June 2026, 11:24 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 10 June 2026, 08:24 | Investor Presentation | Presentations | — | 03026 | |
| 9 June 2026, 08:29 | Investor Webinar Notification | Presentations | — | 14014 | |
| 8 May 2026, 08:17 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 8 May 2026, 08:17 | Board Reorganisation | Company Administration | — | 12008 | |
| 29 Apr 2026, 10:04 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 29 Apr 2026, 08:22 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 |